Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

Information

DOI:
https://doi.org/10.1002/14651858.CD001399.pub4Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 23 August 2015see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:

  1. Cochrane Cystic Fibrosis and Genetic Disorders Group

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

Contributions of authors

The review was designed by Mary Keogan and Helle Krogh Johansen. Both contributed to critical appraisal of papers and data extraction; MK was lead author and drafted the review and subsequent updates, HKJ commented on the drafts.

As from Issue 1, 2006, MK was no longer involved with the review, and Peter C Gøtzsche became co‐author. From this issue, HKJ and PG contributed to appraisal of papers, data extraction and interpretation, and to the writing of the manuscript.

HKJ and PCG are guarantors of the review.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • National Institute for Health Research, UK

    This systematic review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group.

Declarations of interest

Helle Krogh Johansen declares no known conflict of interest.

Peter C Gøtzsche declares no known conflict of interest.

Acknowledgements

We thank Olwen Beaven and Mandy Bryant for performing the searches for this review, Tracey Remmington and Nikki Jahnke for assisting in the update of this review, Joan E Hiller, Gerd Döring and Christoph Meisner for providing additional information on their trials, and Mary Keogan who was an author on previous versions of the review.

Version history

Published

Title

Stage

Authors

Version

2015 Aug 23

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

Review

Helle Krogh Johansen, Peter C Gøtzsche

https://doi.org/10.1002/14651858.CD001399.pub4

2013 Jun 17

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

Review

Helle Krogh Johansen, Peter C Gøtzsche

https://doi.org/10.1002/14651858.CD001399.pub3

2008 Oct 08

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

Review

Helle Krogh Johansen, Peter C Gøtzsche

https://doi.org/10.1002/14651858.CD001399.pub2

1999 Jan 25

Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis

Review

Helle Krogh Johansen, Peter C Gøtzsche, Mary Keogan

https://doi.org/10.1002/14651858.CD001399

Differences between protocol and review

None.

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.